The effect of pulmonary vessel suppression on computerized detection of nodules in chest CT scans.

Med Phys

Shanghai United Imaging Healthcare Co., Ltd., Shanghai, 201807, China.

Published: October 2020

Purpose: In chest computed tomography (CT) scans, pulmonary vessel suppression can make pulmonary nodules more evident, and therefore may increase the detectability of early lung cancer. The purpose of this study was to develop a computer-aided detection (CAD) system with a vessel suppression function and to verify the effectiveness of the vessel suppression on the performance of the pulmonary nodule CAD system.

Methods: A CAD system with a vessel suppression function capable of suppressing vessels and detecting nodules was developed. First, a convolutional neural network (CNN)-based pulmonary vessel suppression technique was employed to remove the vessels from lungs while preserving the nodules. Then, a CNN-based pulmonary nodule detector was utilized to sequentially generate nodule candidates and reduce false positives (FPs). The performance levels of CAD systems with and without the vessel suppression function were compared using 888 three-dimensional chest CT scans from the Lung Nodule Analysis 2016 (LUNA16) dataset. The pulmonary nodule detection results were quantitatively evaluated using the average sensitivity at seven predefined FP rates: 0.125, 0.25, 0.5, 1, 2, 4, and 8 FPs per scan.

Results: The developed pulmonary nodule CAD system improved the average sensitivity to 0.977 from 0.950 owing to the addition of the vessel suppression function.

Conclusions: The vessel suppression function considerably improved the performance of the CAD system for pulmonary nodule detection. In practice, it would be embedded in CAD systems to assist radiologists in detecting pulmonary nodules in chest CT scans.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.14401DOI Listing

Publication Analysis

Top Keywords

vessel suppression
36
pulmonary nodule
20
cad system
16
suppression function
16
pulmonary vessel
12
chest scans
12
pulmonary
10
suppression
9
nodules chest
8
vessel
8

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.

Background: Regional cerebral blood flow (CBF) can be noninvasively quantified using arterial spin labeled (ASL) perfusion MRI. In Alzheimer's disease (AD) and mild cognitive impairment (MCI), hypoperfusion typically occurs in precuneus, posterior cingulate cortex (PCC), and hippocampus. Small vessel disease (SVD), a systemic disorder that commonly underlies vascular cognitive impairment, also causes brain hypoperfusion.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

cheonan chungmu hospital, cheonan si, Korea, Republic of (South).

Background: Vascular contributions to dementia & Alzheimer's disease are increasing recognized. Recent studies have suggested that blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction, including the early clinical stages of AD. Apolipoprotein E4(APOE4), the major AD susceptibility gene, leads to accelerated blood-brain barrier breakdown & degeneration of brain capillary pericyte that maintain blood-brain barrier integrity.

View Article and Find Full Text PDF

Notably, the C-X-C Motif Chemokine Ligand 12/C-X-C Chemokine Receptor Type 4 (CXCL12/CXCR4) signalling pathway's activation is markedly increased in a mouse model of abdominal aortic aneurysms (AAA). Nonetheless, the precise contribution of this pathway to AAA development remains to be elucidated. The AAA mouse model was induced by local incubation with elastase and oral administration of β-aminopropionitrile.

View Article and Find Full Text PDF

Bisphosphonate-mineralized nano-IFNγ suppresses residual tumor growth caused by incomplete radiofrequency ablation through metabolically remodeling tumor-associated macrophages.

Theranostics

January 2025

Beijing Key Laboratory of Molecular Pharmaceutics and Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Radiofrequency ablation (RFA), as a minimally invasive surgery strategy based on local thermal-killing effect, is widely used in the clinical treatment of multiple solid tumors. Nevertheless, RFA cannot achieve the complete elimination of tumor lesions with larger burden or proximity to blood vessels. Incomplete RFA (iRFA) has even been validated to promote residual tumor growth due to the suppressive tumor immune microenvironment (TIME).

View Article and Find Full Text PDF

Asthma is a chronic airway inflammatory disease of the airways characterized by the involvement of numerous inflammatory cells and factors. Therefore, targeting airway inflammation is one of the crucial strategies for developing novel drugs in the treatment of asthma. Phosphoinositide 3-kinase gamma (PI3Kγ) has been demonstrated to have a significant impact on inflammation and immune responses, thus emerging as a promising therapeutic target for airway inflammatory disease, including asthma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!